Table 3.
Excision wound‐healing activity of Cb‐peptide
| Wound contraction (mm)2 | ||||||
|---|---|---|---|---|---|---|
| Groups | Day 0 | Day 5 | Day 10 | Day 15 | Day 21 | Period of epithelialisation |
| Vehicle control | 110.24 ± 6.5 (0.00) | 94.16 ± 2.85 (14.54) | 81.83 ± 3.37 (26.36) | 63 ± 3.34 (37) | 29 ± 3.34 (73.63) | 27.1 ± 0.30 |
| Standard control | 109.5 ± 6.15 (0.00) | 69.89 ± 3.43a (36.69) | 21.66 ± 2.87b (80.7) | 3.5 ± 0.54c (97.2) | 0.00 (100) | 18.16 ± 0.4 |
| Cb‐peptide high dose | 110.26 ± 7.1 (0.00) | 54.66 ± 3.77a (50.90) | 12 ± 1.26c (89.09) | 0.00 (100) | 0.00 (100) | 13.3 ± 0.2 |
| Cb‐peptide low dose | 110.55 ± 5.7 (0.00) | 60.5 ± 2.42b (45.4) | 17.53 ± 1.96c (94.54) | 5.66 ± 1.63c (105.45) | 0.00 (100) | 17.0 ± 0.42 |
Values are expressed as mean ± SEM, n = 6; 1‐way ANOVA followed by Dunnett's t‐test; t‐values denote significance at (a) P < .05, (b) P < .1, (c) P < .001. Percentage of would contraction presented in parenthesis.